NMN and NAD Supplements for Senior Cats in 2026

What Is NAD+ and Why Does It Matter for Ageing Cats?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell. It plays a central role in two processes that define how well a body ages: energy metabolism and DNA repair. NAD+ fuels mitochondria (the energy generators inside cells) and activates a family of proteins called sirtuins, which help regulate inflammation, oxidative stress, and cellular housekeeping.

In younger cats, NAD+ levels are naturally high. As cats move past middle age (generally around seven to ten years), those levels begin to drop. Reduced NAD+ is associated with sluggish mitochondria, accumulating DNA damage, chronic low grade inflammation, and the gradual decline in organ function that veterinary professionals recognise in senior patients.

Chronic kidney disease (CKD), which affects a substantial percentage of cats over ten, involves oxidative stress and mitochondrial dysfunction in renal tubular cells. This overlap between NAD+ biology and kidney ageing is one reason the veterinary longevity community has taken interest in NAD+ precursor supplements.

NMN vs NR: Understanding the NAD+ Precursors

Two NAD+ precursors dominate the supplement market: nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). Both are converted into NAD+ through enzymatic pathways, but they enter the pathway at slightly different points.

• NMN is one step closer to NAD+ in the biosynthetic chain and is converted by the enzyme NMNAT.
• NR must first be phosphorylated by nicotinamide riboside kinases (NRK1 and NRK2) before reaching the NMN stage.

In rodent models, oral NMN supplementation has been shown to raise tissue NAD+ levels in multiple organs, including the liver and kidneys. A 2025 review published in Food Frontiers compared the preclinical and clinical profiles of NMN and NR, noting broadly similar efficacy in raising NAD+ but differences in tissue distribution and bioavailability depending on formulation.

For cats specifically, neither precursor has been evaluated in large scale, peer reviewed feline trials. This is a critical gap. Most dosing and safety claims currently circulating are extrapolated from mouse data and early canine observations.

How to Recognise Age Related Cellular Decline in Cats

Before considering any supplement, owners should learn to identify the subtle signs of cellular and metabolic slowdown in senior cats. These include:

• Decreased activity and longer sleep periods beyond normal feline rest patterns
• Dull, thinning coat with reduced grooming frequency
• Gradual weight loss or muscle wasting, particularly over the spine and hindquarters
• Increased water intake or changes in urination patterns (potential early CKD indicators)
• Cognitive changes such as disorientation, altered sleep/wake cycles, or vocalisation at night
• Slower wound healing or increased susceptibility to minor infections

These signs warrant a full veterinary wellness panel, including blood chemistry and urinalysis, before any supplement protocol is introduced. For more on caring for the ageing feline mouth, see our guide on gentle mouth care for senior cats over ten.

What the Research Says: Promise and Limitations

Rodent Evidence

The most cited body of evidence comes from mouse studies. Long term NMN supplementation in ageing mice has been associated with improved insulin sensitivity, better mitochondrial function, enhanced physical endurance, and markers of reduced age related gene expression changes. Some studies in aged mice have also shown improvements in kidney function markers, which is particularly relevant given the prevalence of feline CKD.

Canine Data

A study involving beagle dogs administered NMN at approximately 1,340 mg per day noted slight increases in creatinine and uric acid, while other biomarkers remained unchanged. This finding underscores the importance of renal monitoring in any companion animal receiving NAD+ precursors, especially at higher doses.

Feline Specific Data

As of early 2026, there are no published, peer reviewed, controlled clinical trials of NMN or NR specifically in domestic cats. The information available comes from manufacturer supported observations, veterinary practitioner reports, and extrapolation from other species. This does not mean NMN is unsafe for cats; it means the evidence base is immature and caution is warranted.

Dosing Protocols by Weight: A Cautious Framework

The following ranges reflect what is currently discussed in the veterinary supplement space. They are not established veterinary standards and should only be used as a starting reference in consultation with a veterinarian.

Important considerations for feline dosing:

• Cats have limited hepatic glucuronidation capacity compared to dogs and humans. This means certain compounds are processed more slowly and can accumulate. While NMN itself is not primarily cleared via glucuronidation, this metabolic difference is a reminder that cats should never be dosed using simple body weight scaling from dog protocols.
• Veterinary professionals suggest introducing NMN gradually and watching for gastrointestinal signs such as reduced appetite, soft stools, or vomiting.
• Visible changes (improved coat quality, increased energy) may take two to six weeks to become apparent in cats, somewhat longer than in dogs.

Veterinary Safety Concerns

Several safety considerations deserve attention before adding NMN or NR to a senior cat's regimen:

Kidney Function Monitoring

The beagle study showing creatinine elevation at high NMN doses raises a flag for any cat, but especially those with existing CKD. Baseline bloodwork (including SDMA, creatinine, BUN, and phosphorus) should be performed before supplementation begins, with a recheck at four to six weeks.

Drug Interactions

NAD+ metabolism intersects with pathways affected by common feline medications, including certain anti inflammatory drugs and thyroid medications. Cats receiving treatment for hyperthyroidism or those on nonsteroidal anti inflammatory drugs should have their supplement plan reviewed by their prescribing veterinarian.

Hyperthyroidism Considerations

Hyperthyroidism is extremely common in older cats and already increases metabolic rate. Adding a supplement that further boosts cellular metabolism could theoretically complicate management, though no direct adverse interactions have been documented in feline literature.

Liver Health

Given the cat's unique hepatic enzyme profile, liver values (ALT, ALP) should be included in monitoring panels for any cat on long term supplementation.

How to Evaluate NMN Product Quality

The pet supplement market is less tightly regulated than human pharmaceuticals. Following these quality checkpoints can help owners avoid ineffective or potentially harmful products:

• Certificate of Analysis (COA): Reputable manufacturers provide COAs from independent, third party laboratories confirming purity (look for 98% or higher NMN content), absence of heavy metals, and microbial safety.
• Manufacturing standards: Products made in facilities following Good Manufacturing Practices (GMP) and registered with relevant regulatory bodies offer a higher baseline of quality control.
• Species specific formulation: Choose products explicitly formulated for cats or small companion animals, rather than generic "pet" supplements designed primarily for dogs. Flavouring agents, fillers, and dosing in dog products may not be appropriate for felines.
• Transparent labelling: The label should clearly state the amount of NMN per serving in milligrams, list all inactive ingredients, and provide a lot or batch number traceable to quality testing records.
• Storage and stability: NMN can degrade with heat and moisture. Products should specify storage conditions and include an expiry date. Liposomal or enteric coated formulations may offer improved stability and absorption.
• Regulatory context: In December 2025, the U.S. FDA confirmed that NMN can be legally marketed as a dietary supplement. In Australia, the TGA listed NMN as a permissible therapeutic ingredient in the same period. These regulatory milestones are encouraging, but pet specific regulations remain limited.

For a related look at how technology intersects with pet health evaluation, see our article on what AI pet DNA tests and genetic reports reveal.

NMN and Kidney Supportive Diets: Complement or Conflict?

Chronic kidney disease is one of the most common conditions in senior cats, with some estimates suggesting it affects up to 40% of cats over ten and an even higher percentage of cats over fifteen. The dietary cornerstone of CKD management, as recommended by organisations such as the International Society of Feline Medicine (ISFM) and supported by research reviewed in veterinary nutrition literature, includes:

• Controlled (not severely restricted) high quality protein to reduce uraemic toxin load while maintaining muscle mass
• Reduced phosphorus to slow disease progression
• Supplemental omega 3 fatty acids (EPA and DHA) to reduce renal inflammation
• Adequate potassium and B vitamins
• Increased moisture content, ideally through wet food

NMN supplementation does not directly conflict with any of these dietary pillars. In theory, by supporting mitochondrial function in remaining nephrons (kidney filtering units), NMN could complement a renal diet's goals. However, this remains speculative in cats. The key precaution is to ensure that any NMN product does not contain additives (excess phosphorus, certain preservatives, or unnecessary sodium) that would undermine the renal diet.

Owners managing a cat with CKD should coordinate NMN introduction with their veterinarian and the cat's existing nutritional plan. Never substitute NMN supplementation for a properly formulated renal diet or prescribed CKD medications such as phosphate binders or antihypertensives.

Our guide on cognitive dysfunction and diet in senior dogs explores parallel nutritional strategies for age related decline in companion animals.

When to See Your Vet and What to Ask

Before starting any NAD+ precursor supplement, schedule a senior wellness visit. Useful questions to raise include:

• Are my cat's kidney values (SDMA, creatinine, BUN, phosphorus) within normal range, and is supplementation appropriate given these results?
• Could NMN interact with any of my cat's current medications, especially thyroid or anti inflammatory drugs?
• What monitoring schedule do you recommend after starting supplementation?
• Is there a particular formulation or product you have seen used safely in feline patients?
• Should we also assess liver values before and during supplementation?

If your veterinarian is unfamiliar with NMN, sharing a summary of the current preclinical evidence and asking for a collaborative, conservative trial approach is a reasonable path forward.

The Bottom Line: Promising but Premature

NAD+ precursors like NMN represent one of the more scientifically grounded entries in the pet longevity supplement space. The underlying biochemistry, declining NAD+ impairing mitochondrial function and cellular repair, is well established across species. The translation to feline clinical practice, however, is still in its early stages.

For owners of senior cats who are interested in exploring NMN supplementation, the evidence supports cautious optimism paired with veterinary partnership. Start low, monitor closely, choose rigorously tested products, and never let a supplement distract from the fundamentals: regular veterinary check ups, appropriate nutrition, hydration, dental care, and environmental enrichment. For cats dealing with the stress of ageing or transitions, our resource on helping a fearful rescue cat build confidence offers practical behavioural support strategies.